| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Artifical intelligence-based model for lymph node metastases detection in bladder cancer
|
Zou, Kang
|
|
|
24 |
6 |
p. e232
|
artikel
|
| 2 |
Artificial intelligence-based model for lymph node metastases detection in bladder cancer
|
Mai, Zhipeng
|
|
|
24 |
6 |
p. e233
|
artikel
|
| 3 |
Artificial intelligence-based model for lymph node metastases detection in bladder cancer – Authors' reply
|
Wu, Shaoxu
|
|
|
24 |
6 |
p. e234
|
artikel
|
| 4 |
Can artificial intelligence improve cancer care?
|
The Lancet Oncology,
|
|
|
24 |
6 |
p. 577
|
artikel
|
| 5 |
Cancer care desperately impeded by fighting in Gaza
|
Gourd, Elizabeth
|
|
|
24 |
6 |
p. e241
|
artikel
|
| 6 |
Cancer research funding data to drive collaboration and inform action
|
Garton, Elise M
|
|
|
24 |
6 |
p. 584-586
|
artikel
|
| 7 |
Cumulative burden of late, major surgical intervention in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study (CCSS) cohort
|
Dieffenbach, Bryan V
|
|
|
24 |
6 |
p. 691-700
|
artikel
|
| 8 |
Dalpiciclib in advanced breast cancer
|
Chen, Xiaosong
|
|
|
24 |
6 |
p. 578-579
|
artikel
|
| 9 |
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
|
Zhang, Pin
|
|
|
24 |
6 |
p. 646-657
|
artikel
|
| 10 |
Dose recommendations for anticancer drugs in patients with renal or hepatic impairment: an update
|
Giraud, Eline L
|
|
|
24 |
6 |
p. e229
|
artikel
|
| 11 |
Enhancing colon cancer care in restricted-resource settings
|
Von Wallwitz Freitas, Laura
|
|
|
24 |
6 |
p. 581-582
|
artikel
|
| 12 |
ESTRO 2023
|
Patodia, Smriti
|
|
|
24 |
6 |
p. e243-e244
|
artikel
|
| 13 |
Extraskeletal osteosarcoma of primary retroperitoneal origin
|
Sapiano, Angeline
|
|
|
24 |
6 |
p. e284
|
artikel
|
| 14 |
G7 Cancer: the priorities and challenges ahead
|
Senior, Kathryn
|
|
|
24 |
6 |
p. e240
|
artikel
|
| 15 |
Global application of National Comprehensive Cancer Network resource-stratified guidelines for systemic treatment of colon cancer: a population-based, customisable model for cost, demand, and procurement
|
Wilson, Brooke E
|
|
|
24 |
6 |
p. 682-690
|
artikel
|
| 16 |
Global democratisation of proton radiotherapy
|
Yan, Susu
|
|
|
24 |
6 |
p. e245-e254
|
artikel
|
| 17 |
Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments
|
McIntosh, Stuart A
|
|
|
24 |
6 |
p. 636-645
|
artikel
|
| 18 |
Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial
|
Fizazi, Karim
|
|
|
24 |
6 |
p. 597-610
|
artikel
|
| 19 |
Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study
|
Jenei, Kristina
|
|
|
24 |
6 |
p. 624-635
|
artikel
|
| 20 |
HPV DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia
|
Jayaraj, Rama
|
|
|
24 |
6 |
p. e236
|
artikel
|
| 21 |
HPV DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia
|
Anil, Abhishek
|
|
|
24 |
6 |
p. e235
|
artikel
|
| 22 |
HPV DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia – Authors' reply
|
Liu, Penglin
|
|
|
24 |
6 |
p. e237
|
artikel
|
| 23 |
Long-term surgical consequences of childhood cancer
|
Youlden, Danny R
|
|
|
24 |
6 |
p. 582-583
|
artikel
|
| 24 |
New US breast cancer screening recommendations
|
Venkatesan, Priya
|
|
|
24 |
6 |
p. e242
|
artikel
|
| 25 |
Polygenic risk scores in cancer screening: a glass half full or half empty?
|
Pashayan, Nora
|
|
|
24 |
6 |
p. 579-581
|
artikel
|
| 26 |
Preoperative chemoradiotherapy or perioperative chemotherapy for patients with gastro-oesophageal junction adenocarcinoma
|
Ilson, David H
|
|
|
24 |
6 |
p. 593-595
|
artikel
|
| 27 |
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
|
Ludwig, Heinz
|
|
|
24 |
6 |
p. e255-e269
|
artikel
|
| 28 |
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis
|
Zlotta, Alexandre R
|
|
|
24 |
6 |
p. 669-681
|
artikel
|
| 29 |
Radiotherapy for children and adolescents with early-stage classical Hodgkin lymphoma
|
Mo, Dun-Chang
|
|
|
24 |
6 |
p. e230
|
artikel
|
| 30 |
Radiotherapy for children and adolescents with early-stage classical Hodgkin lymphoma – Authors' reply
|
Körholz, Dieter
|
|
|
24 |
6 |
p. e231
|
artikel
|
| 31 |
Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer
|
Meirson, Tomer
|
|
|
24 |
6 |
p. 589-593
|
artikel
|
| 32 |
Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer – Authors' reply
|
Johnston, Stephen R D
|
|
|
24 |
6 |
p. e238
|
artikel
|
| 33 |
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis
|
Petit, Claire
|
|
|
24 |
6 |
p. 611-623
|
artikel
|
| 34 |
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures
|
Pe, Madeline
|
|
|
24 |
6 |
p. e270-e283
|
artikel
|
| 35 |
South Africa's new tobacco and e-cigarette control bill
|
Das, Manjulika
|
|
|
24 |
6 |
p. e239
|
artikel
|
| 36 |
Surviving cancer through poetry
|
Kinsey, Caroline A
|
|
|
24 |
6 |
p. 595-596
|
artikel
|
| 37 |
The prognosis of patients with small cell carcinoma of the cervix: a retrospective study of the SEER database and a Chinese multicentre registry
|
Chu, Tian
|
|
|
24 |
6 |
p. 701-708
|
artikel
|
| 38 |
Uterine cancer mortality and Black women: time to act
|
Moss, Esther L
|
|
|
24 |
6 |
p. 586-588
|
artikel
|
| 39 |
Utility of polygenic risk scores in UK cancer screening: a modelling analysis
|
Huntley, Catherine
|
|
|
24 |
6 |
p. 658-668
|
artikel
|
Tijdschrift beschrijving